{"id":"https://openalex.org/W2741570237","doi":"https://doi.org/10.1158/1538-7445.am2017-2356","title":"Abstract 2356: Functional characterization of CDKN1A loss in bladder cancer and effects on cisplatin sensitivity","display_name":"Abstract 2356: Functional characterization of CDKN1A loss in bladder cancer and effects on cisplatin sensitivity","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2741570237","doi":"https://doi.org/10.1158/1538-7445.am2017-2356","mag":"2741570237"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-2356","doi":"https://doi.org/10.1158/1538-7445.am2017-2356","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-2356","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011122559","display_name":"Philip H. Abbosh","orcid":"https://orcid.org/0000-0003-3611-9532","observed_orcids":["https://orcid.org/0000-0003-3611-9532"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip H. Abbosh","raw_affiliation_strings":["Fox Chase Cancer Ctr., Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Ctr., Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040749329","display_name":"Rahmat K. Sikder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rahmat K. Sikder","raw_affiliation_strings":["Fox Chase Cancer Ctr., Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Ctr., Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075201353","display_name":"Wafik S. El\u2010Deiry","orcid":"https://orcid.org/0000-0002-9577-8266","observed_orcids":["https://orcid.org/0000-0002-9577-8266"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wafik S. El-Deiry","raw_affiliation_strings":["Fox Chase Cancer Ctr., Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Ctr., Philadelphia, PA","institution_ids":["https://openalex.org/I1289437631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1289437631"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"2356","last_page":"2356"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.9779999852180481},{"id":"https://openalex.org/keywords/muscle-invasive-bladder-cancer","display_name":"muscle-invasive bladder cancer","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":0.8769999742507935},{"id":"https://openalex.org/keywords/chemosensitivity","display_name":"chemosensitivity","score":0.6489999890327454},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.7070000171661377},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.7649999856948853},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8519999980926514},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.8270000219345093},{"id":"https://openalex.org/keywords/gamma-h2ax","display_name":"\u03b3H2AX","score":0.7080000042915344},{"id":"https://openalex.org/keywords/rb-phosphorylation","display_name":"retinoblastoma protein phosphorylation","score":0.7160000205039978},{"id":"https://openalex.org/keywords/parp-cleavage","display_name":"PARP cleavage","score":0.7710000276565552},{"id":"https://openalex.org/keywords/crispr-knockout","display_name":"CRISPR knockout","score":0.6309999823570251},{"id":"https://openalex.org/keywords/frameshift-mutation","display_name":"frameshift mutation","score":0.5870000123977661},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.4129999876022339},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.4690000116825104},{"id":"https://openalex.org/keywords/cell-cycle-checkpoints","display_name":"cell cycle checkpoints","score":0.30399999022483826}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.8329041004180908},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7057307362556458},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.5836122035980225},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5621570348739624},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.5501471757888794},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5151680707931519},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.4912225604057312},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4907273054122925},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.48375988006591797},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4523296654224396},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4229887127876282},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41358840465545654},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3381601572036743},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.30544620752334595},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.26853489875793457},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.2046414613723755},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15409347414970398}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-2356","doi":"https://doi.org/10.1158/1538-7445.am2017-2356","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-2356","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3109759561","https://openalex.org/W2887555917","https://openalex.org/W3113031067","https://openalex.org/W3043012216","https://openalex.org/W2147531617","https://openalex.org/W3083387252","https://openalex.org/W4403870666","https://openalex.org/W7155899698","https://openalex.org/W2168138060","https://openalex.org/W2069013767"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Muscle-invasive":[2],"bladder":[3,18,450],"cancer":[4,451],"(MIBC)":[5],"is":[6,31,47],"most":[7],"optimally":[8],"treated":[9],"with":[10,87,159,164],"cisplatin-containing":[11],"combination":[12,399],"chemotherapy,":[13],"and":[14,117,132,145,150,154,187,228,270,296,328,331,344,353,359,402,428,452],"if":[15],"clinically":[16],"localized,":[17],"removal.":[19],"With":[20],"recent":[21],"discoveries":[22],"delineating":[23],"aberrant":[24],"driver":[25],"genes":[26],"involved":[27],"in":[28,71,82,103,209,231,237,243,388,449],"MIBC,":[29],"it":[30,417],"now":[32],"possible":[33],"to":[34,63,108,113,143,171,175,189,202,235,386,404,421],"personalize":[35],"treatment":[36,163],"approaches.":[37],"Development":[38],"of":[39,55,85,90,148,219,284,320,378,400,426,446,460],"a":[40,88,127,216,317,367,398],"therapeutic":[41,67,128],"rationale":[42],"for":[43,138,464],"personalized":[44],"therapies":[45],"which":[46],"based":[48,140],"on":[49,141,454],"mutational":[50],"landscape":[51],"or":[52],"other":[53,422],"characteristic":[54],"each":[56],"tumor":[57],"may":[58,418],"prospectively":[59],"identify":[60],"patients":[61],"prone":[62],"chemoresponse,":[64],"thus":[65],"maximizing":[66],"index.":[68],"Inactivating":[69],"mutations":[70],"CDKN1A,":[72],"the":[73,93,110,115,176,179,185,190,282,285,379,461],"gene":[74],"encoding":[75,178],"cyclin":[76,180],"dependent":[77],"kinase":[78],"inhibitor":[79],"p21,":[80],"occur":[81],"about":[83],"14%":[84],"MIBCs,":[86],"majority":[89],"these":[91],"truncating":[92],"peptide.":[94],"We":[95],"hypothesized":[96],"that":[97],"after":[98,162,215],"DNA-damaging":[99],"events,":[100],"cells":[101,304,322],"deficient":[102],"p21":[104,239,357,410],"would":[105],"be":[106],"unable":[107],"halt":[109],"cell":[111,134,211,245,267,338,390,395],"cycle":[112,268],"repair":[114,403],"damage,":[116],"subsequently":[118],"proceed":[119],"down":[120],"an":[121,360,406],"apoptotic":[122,155,407],"pathway,":[123],"potentially":[124],"serving":[125],"as":[126,309],"vulnerability.":[129],"Methods":[130],"RT4":[131,232,303],"SW780":[133,277,321],"lines":[135,212,396],"were":[136,157,169,195,342],"chosen":[137],"study":[139],"chemoresistance":[142],"cisplatin":[144,220,387,415,455],"WT":[146],"status":[147],"CDKN1A":[149,339,374,447],"TP53.":[151],"Cell-cycle":[152],"arrest":[153,401],"pathways":[156],"evaluated":[158],"Western":[160],"blot":[161],"IC50":[165],"doses.":[166],"CRISPR":[167],"sgRNAs":[168,348],"generated":[170,343,366],"introduce":[172],"frameshifts":[173],"5\u2019":[174,188],"regions":[177],"binding":[181,192],"domain":[182],"(CDI),":[183],"within":[184],"CDI,":[186],"PCNA":[191],"domains.":[193],"Knock-outs":[194],"confirmed":[196,345],"by":[197,311,346],"immunoblot.":[198],"MTT":[199],"was":[200,240,291,333],"used":[201],"assess":[203],"cipslatin":[204],"response.":[205],"Results":[206],"p53":[207,223],"increased":[208,297],"both":[210,244],"24":[213,226,249,264,294],"hours":[214,227,295,300,330],"3h":[217],"pulse":[218],"exposure.":[221],"However,":[222],"peaked":[224],"at":[225,248,253,263,273,293,298,326,376],"then":[229,251],"diminished":[230],"but":[233],"continued":[234],"rise":[236],"SW780.":[238],"basally":[241],"expressed":[242],"lines,":[246],"decreased":[247,272],"hours,":[250,265],"increasing":[252],"72":[254,274,329],"hours.":[255,275],"In":[256,276,287,315],"RT4,":[257,288],"peak":[258],"Rb":[259],"phosphorylation":[260],"(pRb)":[261],"occurred":[262],"indicating":[266,301],"arrest,":[269],"gradually":[271],"pRb":[278],"remained":[279],"unchanged":[280],"during":[281],"course":[283],"treatment.":[286],"PARP":[289,324],"cleavage":[290,325],"observed":[292],"48":[299,327],"apoptosis.":[302],"harbored":[305],"extensive":[306],"DNA":[307],"damage":[308],"indicated":[310],"persistent":[312],"phosphorylated":[313,335],"\u03b3H2AX.":[314,336],"contrast":[316],"smaller":[318],"fraction":[319],"underwent":[323],"there":[332],"less":[334],"Single":[337],"knockout":[340],"clones":[341],"immunoblotting.":[347],"targeting":[349,362],"amino":[350,363],"acids":[351],"12":[352],"59":[354],"completely":[355],"abolished":[356],"detection,":[358],"sgRNA":[361],"acid":[364],"109":[365],"truncated":[368],"peptide,":[369],"confirming":[370],"p21\u2019s":[371],"apparent":[372],"stability.":[373],"disruption":[375],"any":[377],"three":[380],"sites":[381],"did":[382,412],"not":[383,413],"reverse":[384,414],"chemorensitance":[385],"either":[389],"line.":[391],"Conclusion":[392],"Cisplatin":[393],"resistant":[394],"use":[397],"survive":[405],"insult.":[408],"Although":[409],"loss":[411,448],"resistance,":[416],"impact":[419],"sensitivity":[420,456],"agents.":[423],"Other":[424],"mechanisms":[425],"chemo-":[427],"radio-sensitization":[429],"are":[430],"being":[431],"explored.":[432],"Citation":[433],"Format:":[434],"Philip":[435],"H.":[436],"Abbosh,":[437],"Rahmat":[438],"K.":[439],"Sikder,":[440],"Wafik":[441],"S.":[442],"El-Deiry.":[443],"Functional":[444],"characterization":[445],"effects":[453],"[abstract].":[457],"In:":[458],"Proceedings":[459],"American":[462],"Association":[463],"Cancer":[465,478],"Research":[466],"Annual":[467],"Meeting":[468],"2017;":[469],"2017":[470],"Apr":[471],"1-5;":[472],"Washington,":[473],"DC.":[474],"Philadelphia":[475],"(PA):":[476],"AACR;":[477],"Res":[479],"2017;77(13":[480],"Suppl):Abstract":[481],"nr":[482],"2356.":[483],"doi:10.1158/1538-7445.AM2017-2356":[484]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2017-08-08T00:00:00"}
